Showing 1 - 2 results of 2 for search 'Yirui Dong', query time: 0.02s Refine Results
  1. 1
    High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer

    High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer by Jing Liang, Haodi Ma, Shunshun Zhang, Yirui Dong, Jiayu Zheng, Li Zeng, Xin Xiong, Wenbin Huang, Qinan Yin, Xuewei Zheng

    Published 2024-08-01
    Get full text
    Article
  2. 2
    The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment

    The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment by Qinan Yin, Haodi Ma, Yirui Dong, Shunshun Zhang, Junxiang Wang, Jing Liang, Longfei Mao, Li Zeng, Xin Xiong, Xingang Chen, Jingjing Wang, Xuewei Zheng

    Published 2024-01-01
    Get full text
    Article

Search Tools: